CARFILZOMIB

CARFILZOMIB was reported 28379 times

CARFILZOMIB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 SARS-COV-2 SEPSIS 15 0.4167
1 CEREBELLAR HAEMANGIOMA 9 0.3750
2 PLASMA CELL MYELOMA REFRACTORY 472 0.3528
3 LYMPHODEPLETION 10 0.2941
4 GLOBAL LONGITUDINAL STRAIN ABNORMAL 14 0.2545
5 PLASMA CELL LEUKAEMIA 120 0.2000
6 PLASMA CELLS INCREASED 14 0.1918
7 MYELOMA CAST NEPHROPATHY 23 0.1620
8 LIGHT CHAIN DISEASE 23 0.1586
9 PLASMACYTOMA 191 0.1025
10 PLASMA CELL MYELOMA RECURRENT 322 0.0990
11 REFRACTORY CANCER 18 0.0841
12 LIGHT CHAIN ANALYSIS INCREASED 86 0.0833
13 PLASMA CELL MYELOMA 3057 0.0783
14 MYELODYSPLASTIC SYNDROME WITH EXCESS BLASTS 9 0.0738
15 PNEUMONIA PARAINFLUENZAE VIRAL 12 0.0706
16 PULMONARY INTERSTITIAL EMPHYSEMA SYNDROME 10 0.0704
17 BLOOD STEM CELL HARVEST FAILURE 10 0.0676
18 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 53 0.0652
19 MONOCLONAL IMMUNOGLOBULIN INCREASED 18 0.0629
20 LIGHT CHAIN ANALYSIS ABNORMAL 13 0.0625
21 DONOR SPECIFIC ANTIBODY PRESENT 9 0.0584
22 PARAPROTEINAEMIA 18 0.0581
23 MICROANGIOPATHIC HAEMOLYTIC ANAEMIA 39 0.0495
24 HYPERVISCOSITY SYNDROME 14 0.0486
25 MORGANELLA INFECTION 14 0.0478
26 MINIMAL RESIDUAL DISEASE 23 0.0476
27 BRONCHOPNEUMOPATHY 16 0.0435
28 THROMBOTIC MICROANGIOPATHY 418 0.0428
29 MONOCLONAL IMMUNOGLOBULIN PRESENT 32 0.0421
30 HAEMOLYTIC URAEMIC SYNDROME 96 0.0414
31 BODY DYSMORPHIC DISORDER 15 0.0400
32 B-CELL APLASIA 10 0.0388
33 INFESTATION 10 0.0386
34 FEBRILE INFECTION 44 0.0374
35 OSTEOLYSIS 74 0.0362
36 THERAPY PARTIAL RESPONDER 558 0.0357
37 BRONCHIAL HAEMORRHAGE 11 0.0353
38 BONE MARROW INFILTRATION 13 0.0336
39 CEREBRAL TOXOPLASMOSIS 30 0.0321
40 BILE ACID MALABSORPTION 9 0.0319
41 B-CELL TYPE ACUTE LEUKAEMIA 23 0.0313
42 INTERCEPTED PRODUCT PREPARATION ERROR 367 0.0298
43 CANDIDA PNEUMONIA 9 0.0279
44 PNEUMONIA INFLUENZAL 33 0.0277
45 TUMOUR LYSIS SYNDROME 243 0.0276
46 CYTOPENIA 328 0.0268
47 JOINT ANKYLOSIS 15 0.0264
48 HYPOGAMMAGLOBULINAEMIA 173 0.0263
49 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 22 0.0261
50 SEPSIS SYNDROME 13 0.0259
51 DISSEMINATED VARICELLA ZOSTER VIRUS INFECTION 9 0.0248
52 PNEUMOCOCCAL SEPSIS 16 0.0244
53 MENINGITIS LISTERIA 12 0.0235
54 B PRECURSOR TYPE ACUTE LEUKAEMIA 9 0.0232
55 BLOOD IMMUNOGLOBULIN M INCREASED 14 0.0230
56 CENTRAL NERVOUS SYSTEM VASCULITIS 11 0.0216
57 CARDIAC AMYLOIDOSIS 23 0.0209
58 INFLUENZA A VIRUS TEST POSITIVE 9 0.0209
59 AMYLOIDOSIS 36 0.0209
60 BLOOD IMMUNOGLOBULIN A INCREASED 11 0.0204
61 PARAINFLUENZAE VIRUS INFECTION 31 0.0204
62 DEVICE RELATED THROMBOSIS 20 0.0203
63 OESOPHAGEAL INFECTION 9 0.0201
64 MENINGOENCEPHALITIS HERPETIC 9 0.0201
65 THROMBOTIC THROMBOCYTOPENIC PURPURA 70 0.0198
66 IMMUNOGLOBULINS DECREASED 27 0.0197
67 BRAIN NATRIURETIC PEPTIDE INCREASED 56 0.0181
68 KLEBSIELLA BACTERAEMIA 17 0.0179
69 SUPERFICIAL VEIN THROMBOSIS 15 0.0178
70 JC VIRUS INFECTION 28 0.0175
71 ESCHERICHIA BACTERAEMIA 41 0.0174
72 PULMONARY SEPSIS 25 0.0172
73 KERATOPATHY 27 0.0171
74 BONE LESION 60 0.0166
75 GASTROINTESTINAL TOXICITY 79 0.0164
76 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 10 0.0163
77 PLEURAL DISORDER 10 0.0159
78 DEVICE RELATED SEPSIS 32 0.0159
79 ESSENTIAL HYPERTENSION 29 0.0158
80 PROTEIN TOTAL INCREASED 42 0.0158
81 ALVEOLAR PROTEINOSIS 9 0.0152
82 HYPERTENSIVE ENCEPHALOPATHY 9 0.0152
83 ALBUMINURIA 8 0.0150
84 INTERVERTEBRAL DISCITIS 27 0.0143
85 HEPATITIS B REACTIVATION 45 0.0142
86 ACUTE PULMONARY OEDEMA 79 0.0141
87 PSEUDOMONAL BACTERAEMIA 12 0.0141
88 SECONDARY IMMUNODEFICIENCY 17 0.0140
89 THROMBOCYTOPENIA 1551 0.0139
90 HEPATITIS VIRAL 11 0.0137
91 CARDIAC DYSFUNCTION 51 0.0137
92 LYMPHOPENIA 193 0.0136
93 SALMONELLOSIS 23 0.0136
94 PNEUMONIA PNEUMOCOCCAL 20 0.0135
95 COVID-19 PNEUMONIA 158 0.0134
96 INTERCEPTED PRODUCT ADMINISTRATION ERROR 102 0.0133
97 PATHOLOGICAL FRACTURE 65 0.0128
98 MICROANGIOPATHY 12 0.0128
99 DIARRHOEA INFECTIOUS 10 0.0127
100 ENDOMETRIAL ADENOCARCINOMA 8 0.0126
101 PNEUMONIA MYCOPLASMAL 10 0.0126
102 INFECTION IN AN IMMUNOCOMPROMISED HOST 9 0.0125
103 MYOCARDIAL NECROSIS MARKER INCREASED 21 0.0125
104 RHINOVIRUS INFECTION 48 0.0123
105 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 17 0.0121
106 POLYNEUROPATHY 145 0.0121
107 ACUTE LEFT VENTRICULAR FAILURE 8 0.0119
108 BONE MARROW DISORDER 36 0.0119
109 LEFT VENTRICULAR FAILURE 41 0.0119
110 INFECTIOUS PLEURAL EFFUSION 18 0.0118
111 CYTOKINE RELEASE SYNDROME 237 0.0118
112 STEM CELL TRANSPLANT 29 0.0116
113 KLEBSIELLA SEPSIS 13 0.0115
114 BLOOD IMMUNOGLOBULIN G INCREASED 14 0.0115
115 CARDIOTOXICITY 102 0.0114
116 H1N1 INFLUENZA 16 0.0114
117 SYSTOLIC DYSFUNCTION 12 0.0114
118 ESCHERICHIA SEPSIS 33 0.0114
119 HERPES ZOSTER DISSEMINATED 9 0.0112
120 EMBOLISM VENOUS 34 0.0112
121 DILATED CARDIOMYOPATHY 11 0.0109
122 CARDIAC FAILURE ACUTE 72 0.0108
123 BACTERIAL SEPSIS 35 0.0107
124 EJECTION FRACTION ABNORMAL 13 0.0106
125 TRANSPLANT 25 0.0105
126 VASCULAR PAIN 10 0.0105
127 MALIGNANT HYPERTENSION 9 0.0105
128 SOFT TISSUE INFECTION 19 0.0104
129 DIASTOLIC DYSFUNCTION 32 0.0104
130 HYPERCALCAEMIA 128 0.0104
131 HAEMOLYTIC ANAEMIA 92 0.0103
132 ACUTE LYMPHOCYTIC LEUKAEMIA 29 0.0102
133 HEPATITIS E 16 0.0101
134 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 96 0.0100
135 PROTEIN TOTAL ABNORMAL 13 0.0100
136 HAPTOGLOBIN DECREASED 8 0.0099
137 ANAL ULCER 8 0.0098
138 HAEMATOTOXICITY 93 0.0098
139 INFECTION SUSCEPTIBILITY INCREASED 21 0.0096
140 PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY 79 0.0096
141 ISCHAEMIC CEREBRAL INFARCTION 11 0.0095
142 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 55 0.0093
143 LEFT VENTRICULAR DYSFUNCTION 62 0.0092
144 STREPTOCOCCAL BACTERAEMIA 10 0.0092
145 PSEUDOMONAL SEPSIS 16 0.0091
146 PNEUMONIA STREPTOCOCCAL 10 0.0091
147 EJECTION FRACTION DECREASED 141 0.0091
148 CYTOMEGALOVIRUS INFECTION REACTIVATION 40 0.0090
149 INFUSION SITE EXTRAVASATION 56 0.0090
150 ATRIAL FLUTTER 71 0.0089
151 VENTRICULAR DYSFUNCTION 23 0.0089
152 PNEUMONIA CYTOMEGALOVIRAL 17 0.0087
153 MYELOSUPPRESSION 315 0.0087
154 INFECTION REACTIVATION 10 0.0087
155 NEUTROPENIC COLITIS 18 0.0087
156 APLASIA 17 0.0087
157 ENTEROCOLITIS INFECTIOUS 8 0.0087
158 THROMBOPHLEBITIS 30 0.0085
159 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 284 0.0084
160 PULMONARY HYPERTENSION 175 0.0084
161 NEUTROPENIA 1127 0.0083
162 FEBRILE BONE MARROW APLASIA 35 0.0082
163 MYELODYSPLASTIC SYNDROME 119 0.0082
164 NORMOCYTIC ANAEMIA 12 0.0082
165 HAEMOLYSIS 63 0.0082
166 HYPOPHOSPHATAEMIA 60 0.0081
167 GRANULOCYTE COUNT DECREASED 15 0.0081
168 PANCYTOPENIA 452 0.0081
169 MYOCARDIAL INJURY 9 0.0080
170 PALLIATIVE CARE 12 0.0078
171 PHLEBITIS 40 0.0078
172 PRERENAL FAILURE 11 0.0078
173 BACTERAEMIA 92 0.0077
174 MENINGITIS BACTERIAL 11 0.0077
175 BRONCHOPULMONARY ASPERGILLOSIS 58 0.0075
176 OCCUPATIONAL EXPOSURE TO PRODUCT 48 0.0075
177 NEUROPATHY PERIPHERAL 703 0.0074
178 FEBRILE CONVULSION 9 0.0074
179 RESPIRATORY TRACT INFECTION 192 0.0074
180 KLEBSIELLA INFECTION 36 0.0071
181 CARDIAC FAILURE 570 0.0071
182 FIBROSIS 21 0.0068
183 VENOUS THROMBOSIS LIMB 14 0.0068
184 LEUKOPENIA 335 0.0067
185 STAPHYLOCOCCAL BACTERAEMIA 29 0.0067
186 HYPERTENSIVE CRISIS 74 0.0066
187 NOCARDIOSIS 17 0.0066
188 TROPONIN I INCREASED 11 0.0066
189 ACUTE RESPIRATORY FAILURE 126 0.0065
190 EMBOLISM 54 0.0065
191 BLOOD DISORDER 52 0.0065
192 NEPHROGENIC ANAEMIA 30 0.0065
193 PNEUMONIA BACTERIAL 59 0.0064
194 THERAPY NON-RESPONDER 286 0.0064
195 CUTANEOUS T-CELL LYMPHOMA 8 0.0063
196 FEBRILE NEUTROPENIA 420 0.0063
197 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 24 0.0063
198 ENDOCRINE DISORDER 8 0.0062
199 RESPIRATORY SYNCYTIAL VIRUS INFECTION 54 0.0062
200 EXTRAVASATION 25 0.0061
201 GENE MUTATION 12 0.0061
202 METHAEMOGLOBINAEMIA 14 0.0060
203 ACUTE CORONARY SYNDROME 50 0.0060
204 NEUTROPHIL COUNT ABNORMAL 17 0.0060
205 RESPIRATORY TRACT INFECTION VIRAL 14 0.0060
206 PNEUMONIA VIRAL 19 0.0060
207 DISEASE PROGRESSION 705 0.0060
208 PNEUMONIA PSEUDOMONAL 9 0.0059
209 ANAEMIA 1119 0.0059
210 SQUAMOUS CELL CARCINOMA OF SKIN 35 0.0058
211 CLOSTRIDIUM DIFFICILE COLITIS 61 0.0057
212 VENTRICULAR ARRHYTHMIA 21 0.0057
213 ECHOCARDIOGRAM ABNORMAL 8 0.0057
214 ACUTE KIDNEY INJURY 874 0.0057
215 HYPOCALCAEMIA 108 0.0057
216 PULMONARY ALVEOLAR HAEMORRHAGE 32 0.0057
217 BLOOD CALCIUM INCREASED 50 0.0057
218 ATYPICAL PNEUMONIA 17 0.0057
219 PLATELET COUNT DECREASED 604 0.0057
220 SPINAL CORD COMPRESSION 22 0.0056
221 ASPERGILLUS INFECTION 37 0.0056
222 CARDIAC FAILURE CHRONIC 24 0.0056
223 JUGULAR VEIN THROMBOSIS 10 0.0056
224 BICYTOPENIA 11 0.0056
225 HYPERURICAEMIA 23 0.0056
226 PNEUMOCYSTIS JIROVECII PNEUMONIA 56 0.0056
227 URINARY TRACT INFECTION BACTERIAL 14 0.0055
228 OESOPHAGEAL CANDIDIASIS 22 0.0055
229 CANCER PAIN 14 0.0055
230 PERIPHERAL SENSORY NEUROPATHY 32 0.0055
231 HYPERVOLAEMIA 27 0.0055
232 LABORATORY TEST ABNORMAL 161 0.0055
233 OTOTOXICITY 10 0.0054
234 ENTEROCOLITIS HAEMORRHAGIC 8 0.0054
235 INFUSION SITE INDURATION 8 0.0054
236 NEUTROPHIL COUNT DECREASED 220 0.0054
237 PSEUDOMEMBRANOUS COLITIS 12 0.0054
238 SEPSIS 598 0.0054
239 INFUSION SITE PAIN 69 0.0053
240 QUADRIPLEGIA 11 0.0053
241 FULL BLOOD COUNT DECREASED 106 0.0053
242 ACUTE SINUSITIS 9 0.0052
243 SYSTEMIC CANDIDA 13 0.0052
244 ANAEMIA MACROCYTIC 11 0.0051
245 PLATELET COUNT ABNORMAL 31 0.0051
246 CYTOMEGALOVIRUS CHORIORETINITIS 10 0.0051
247 CARDIOMYOPATHY 75 0.0051
248 PNEUMONIA FUNGAL 20 0.0051
249 NON-CARDIAC CHEST PAIN 16 0.0051
250 COMPRESSION FRACTURE 27 0.0050
251 VENTRICULAR HYPOKINESIA 16 0.0050
252 MULTIPLE ORGAN DYSFUNCTION SYNDROME 141 0.0050
253 THROMBOPHLEBITIS SUPERFICIAL 15 0.0049
254 SEPTIC SHOCK 214 0.0049
255 DEEP VEIN THROMBOSIS 319 0.0049
256 PSEUDOMONAS INFECTION 42 0.0049
257 UPPER RESPIRATORY TRACT INFECTION 226 0.0049
258 INFUSION SITE ERYTHEMA 41 0.0049
259 ESCHERICHIA INFECTION 40 0.0049
260 SPINAL COMPRESSION FRACTURE 40 0.0048
261 BLOOD CALCIUM ABNORMAL 8 0.0048
262 ACUTE MYELOID LEUKAEMIA 75 0.0048
263 CONGESTIVE CARDIOMYOPATHY 20 0.0048
264 ANXIETY DISORDER 16 0.0048
265 ACUTE RESPIRATORY DISTRESS SYNDROME 84 0.0047
266 TROPONIN INCREASED 36 0.0047
267 SUDDEN DEATH 50 0.0047
268 INFECTION 681 0.0047
269 MUCOSAL INFLAMMATION 123 0.0047
270 MYOCARDIAL ISCHAEMIA 53 0.0047
271 NEUTROPENIC SEPSIS 33 0.0046
272 VENOUS THROMBOSIS 18 0.0046
273 LEUKOENCEPHALOPATHY 17 0.0046
274 UNEVALUABLE EVENT 345 0.0046
275 TRICUSPID VALVE INCOMPETENCE 36 0.0045
276 PRODUCT PREPARATION ERROR 92 0.0045
277 BLOOD IMMUNOGLOBULIN G DECREASED 11 0.0044
278 THORACIC VERTEBRAL FRACTURE 13 0.0044
279 PULMONARY OEDEMA 196 0.0044
280 PRODUCT STORAGE ERROR 383 0.0044
281 PNEUMONITIS 119 0.0044
282 BRAIN ABSCESS 11 0.0043
283 PNEUMONIA 1398 0.0043
284 REFUSAL OF TREATMENT BY PATIENT 28 0.0043
285 BRONCHIOLITIS 15 0.0043
286 VIRAL UPPER RESPIRATORY TRACT INFECTION 20 0.0042
287 SUPRAVENTRICULAR TACHYCARDIA 40 0.0042
288 RETINAL VEIN OCCLUSION 12 0.0042
289 GRAFT VERSUS HOST DISEASE 30 0.0042
290 DISEASE COMPLICATION 19 0.0041
291 DEVICE RELATED INFECTION 63 0.0041
292 ELECTROCARDIOGRAM T WAVE INVERSION 9 0.0041
293 PULSELESS ELECTRICAL ACTIVITY 17 0.0041
294 BLOOD CREATININE ABNORMAL 14 0.0040
295 PARESIS 9 0.0040
296 GASTRIC PERFORATION 11 0.0040
297 PULMONARY ARTERIAL HYPERTENSION 58 0.0040
298 VEIN DISORDER 20 0.0040
299 INFUSION RELATED REACTION 261 0.0039
300 SKIN TOXICITY 22 0.0039
301 PLEURISY 23 0.0039
302 LUNG INFILTRATION 34 0.0038
303 SECOND PRIMARY MALIGNANCY 32 0.0038
304 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 9 0.0038
305 NEOPLASM RECURRENCE 13 0.0038
306 CYTOMEGALOVIRUS VIRAEMIA 17 0.0038
307 INFUSION SITE SWELLING 24 0.0038
308 HICCUPS 31 0.0038
309 ACUTE MYOCARDIAL INFARCTION 111 0.0038
310 ESCHERICHIA URINARY TRACT INFECTION 16 0.0038
311 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 8 0.0038
312 ATRIAL FIBRILLATION 366 0.0038
313 PULMONARY EMBOLISM 355 0.0037
314 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 28 0.0037
315 RESPIRATORY FAILURE 272 0.0037
316 HYPOALBUMINAEMIA 29 0.0037
317 RIGHT VENTRICULAR FAILURE 26 0.0037
318 FAILURE TO THRIVE 19 0.0037
319 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 8 0.0036
320 STRESS CARDIOMYOPATHY 21 0.0036
321 BONE MARROW FAILURE 73 0.0036
322 RESPIRATORY DISTRESS 99 0.0036
323 FLUID OVERLOAD 52 0.0036
324 NEPHROPATHY TOXIC 40 0.0036
325 COLITIS ISCHAEMIC 24 0.0036
326 CYTOMEGALOVIRUS INFECTION 59 0.0035
327 WHITE BLOOD CELL COUNT DECREASED 384 0.0035
328 CARDIAC FAILURE CONGESTIVE 284 0.0035
329 PULMONARY TOXICITY 25 0.0035
330 RENAL FAILURE 467 0.0035
331 CEREBRAL ISCHAEMIA 18 0.0035
332 CHRONIC SINUSITIS 13 0.0035
333 VENOOCCLUSIVE LIVER DISEASE 17 0.0034
334 DECUBITUS ULCER 28 0.0034
335 HYPOXIA 121 0.0034
336 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 9 0.0034
337 HAEMOGLOBIN ABNORMAL 22 0.0034
338 PYREXIA 1176 0.0034
339 HYPERTENSION 717 0.0034
340 INFUSION SITE REACTION 10 0.0033
341 METABOLIC ENCEPHALOPATHY 10 0.0033
342 LUNG ADENOCARCINOMA 10 0.0033
343 SINUS BRADYCARDIA 32 0.0033
344 KERATITIS 10 0.0033
345 LUNG INFECTION 51 0.0033
346 HEPATOTOXICITY 73 0.0033
347 MITRAL VALVE INCOMPETENCE 37 0.0033
348 HOSPICE CARE 32 0.0032
349 GASTROINTESTINAL INFECTION 29 0.0032
350 MONOPLEGIA 14 0.0032
351 NEPHROTIC SYNDROME 22 0.0032
352 SQUAMOUS CELL CARCINOMA 30 0.0032
353 ERYSIPELAS 16 0.0032
354 TACHYPNOEA 43 0.0032
355 BLOOD LACTATE DEHYDROGENASE INCREASED 50 0.0032
356 RED BLOOD CELL COUNT DECREASED 90 0.0031
357 HUMERUS FRACTURE 15 0.0031
358 ENTEROCOCCAL INFECTION 15 0.0031
359 HYPOMAGNESAEMIA 43 0.0031
360 SPINAL PAIN 36 0.0031
361 LEFT VENTRICULAR HYPERTROPHY 13 0.0030
362 BLOOD PHOSPHORUS DECREASED 11 0.0030
363 HEPATITIS B 18 0.0030
364 CLOSTRIDIUM DIFFICILE INFECTION 65 0.0030
365 PULMONARY HAEMORRHAGE 23 0.0029
366 AUTOIMMUNE HAEMOLYTIC ANAEMIA 10 0.0029
367 BONE PAIN 169 0.0029
368 CORONAVIRUS INFECTION 19 0.0029
369 ENCEPHALOPATHY 70 0.0028
370 MUSCULOSKELETAL CHEST PAIN 44 0.0028
371 RENAL DISORDER 132 0.0028
372 BUNDLE BRANCH BLOCK RIGHT 13 0.0028
373 BUNDLE BRANCH BLOCK LEFT 12 0.0028
374 ORTHOPNOEA 9 0.0028
375 INFLAMMATORY MARKER INCREASED 14 0.0028
376 HEPATIC CYTOLYSIS 36 0.0028
377 COVID-19 493 0.0028
378 LOCALISED OEDEMA 13 0.0028
379 RASH MACULO-PAPULAR 62 0.0028
380 GINGIVITIS 15 0.0028
381 HYPOKALAEMIA 128 0.0028
382 CARDIAC DISORDER 259 0.0028
383 OFF LABEL USE 2413 0.0028
384 FEMORAL NECK FRACTURE 14 0.0027
385 PULMONARY CONGESTION 36 0.0027
386 IMMUNOSUPPRESSION 24 0.0027
387 CARDIOGENIC SHOCK 39 0.0027
388 PLEURAL EFFUSION 165 0.0027
389 ATELECTASIS 26 0.0027
390 INFLUENZA 300 0.0027
391 ARRHYTHMIA 127 0.0027
392 ANURIA 23 0.0027
393 ELECTROCARDIOGRAM QT PROLONGED 96 0.0027
394 GENERALISED OEDEMA 33 0.0027
395 LYMPHOCYTE COUNT DECREASED 47 0.0027
396 PROTEIN TOTAL DECREASED 10 0.0027
397 CATHETER SITE INFECTION 10 0.0026
398 CRANIOCEREBRAL INJURY 8 0.0026
399 BONE DISORDER 48 0.0026
400 HYPERTHERMIA 20 0.0026
401 RENAL IMPAIRMENT 220 0.0026
402 HYPERGLYCAEMIA 95 0.0026
403 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
404 UROSEPSIS 24 0.0026
405 MALNUTRITION 29 0.0026
406 AORTIC VALVE INCOMPETENCE 11 0.0026
407 NEUROTOXICITY 45 0.0026
408 NECROTISING FASCIITIS 9 0.0026
409 ADVERSE EVENT 235 0.0025
410 HAEMOGLOBIN DECREASED 261 0.0025
411 WHITE BLOOD CELL COUNT ABNORMAL 16 0.0025
412 CHOLECYSTITIS ACUTE 14 0.0025
413 BLOOD CREATININE INCREASED 161 0.0025
414 SINUS TACHYCARDIA 35 0.0025
415 MALIGNANT MELANOMA 33 0.0025
416 ATRIOVENTRICULAR BLOCK 19 0.0025
417 HAEMORRHOIDAL HAEMORRHAGE 12 0.0025
418 ENCEPHALITIS 17 0.0025
419 DRUG RESISTANCE 63 0.0025
420 RECURRENT CANCER 10 0.0024
421 CARDIOVASCULAR DISORDER 62 0.0024
422 NEOPLASM 28 0.0024
423 WALKING AID USER 16 0.0024
424 VASCULAR DEVICE INFECTION 11 0.0024
425 OVERWEIGHT 13 0.0024
426 APPETITE DISORDER 16 0.0024
427 ADVERSE REACTION 32 0.0024
428 HEPATIC NECROSIS 9 0.0024
429 BLOOD COUNT ABNORMAL 36 0.0024
430 INTERCEPTED MEDICATION ERROR 11 0.0024
431 CARDIOMEGALY 29 0.0024
432 STREPTOCOCCAL INFECTION 13 0.0023
433 PERICARDITIS 39 0.0023
434 ANGIOPATHY 13 0.0023
435 AGRANULOCYTOSIS 43 0.0023
436 DERMATITIS EXFOLIATIVE GENERALISED 8 0.0023
437 ISCHAEMIC STROKE 41 0.0023
438 AORTIC STENOSIS 8 0.0023
439 PERICARDIAL EFFUSION 53 0.0023
440 NEUROLOGICAL SYMPTOM 13 0.0023
441 ABDOMINAL ABSCESS 10 0.0023
442 GASTROENTERITIS 33 0.0023
443 SUBARACHNOID HAEMORRHAGE 23 0.0023
444 MENINGITIS 15 0.0022
445 BLEPHARITIS 9 0.0022
446 EPSTEIN-BARR VIRUS INFECTION 14 0.0022
447 DYSPNOEA EXERTIONAL 84 0.0022
448 PAPILLOEDEMA 10 0.0022
449 INTENTIONAL PRODUCT USE ISSUE 193 0.0022
450 IMMUNE SYSTEM DISORDER 29 0.0022
451 OSTEONECROSIS OF JAW 54 0.0022
452 MYOCARDITIS 25 0.0022
453 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 155 0.0022
454 THROMBOSIS 175 0.0022
455 RED CELL DISTRIBUTION WIDTH INCREASED 9 0.0022
456 ELECTROLYTE IMBALANCE 25 0.0021
457 BRONCHITIS 159 0.0021
458 PERFORMANCE STATUS DECREASED 10 0.0021
459 RENAL TUBULAR NECROSIS 21 0.0021
460 PRODUCT PREPARATION ISSUE 14 0.0021
461 VIRAL INFECTION 71 0.0021
462 DIVERTICULITIS 59 0.0021
463 MENTAL STATUS CHANGES 59 0.0021
464 LUNG DISORDER 104 0.0021
465 DIALYSIS 30 0.0021
466 RIB FRACTURE 43 0.0021
467 SERUM FERRITIN INCREASED 11 0.0021
468 TUMOUR MARKER INCREASED 10 0.0021
469 FULL BLOOD COUNT ABNORMAL 22 0.0021
470 CANDIDA INFECTION 35 0.0021
471 METABOLIC DISORDER 12 0.0021
472 GENERAL PHYSICAL CONDITION ABNORMAL 14 0.0021
473 BLOOD TEST ABNORMAL 29 0.0021
474 DEATH 1768 0.0021
475 SYNCOPE 205 0.0020
476 GASTROINTESTINAL INFLAMMATION 16 0.0020
477 DECREASED IMMUNE RESPONSIVENESS 20 0.0020
478 CELLULITIS 101 0.0020
479 MASS 28 0.0020
480 AZOTAEMIA 8 0.0020
481 LIVER FUNCTION TEST INCREASED 43 0.0020
482 IRON DEFICIENCY 9 0.0020
483 VENTRICULAR TACHYCARDIA 33 0.0020
484 FATIGUE 1549 0.0020
485 ANGINA PECTORIS 57 0.0020
486 BACTERIAL INFECTION 37 0.0020
487 DYSPNOEA 1122 0.0020
488 SKIN INFECTION 22 0.0020
489 SPINAL FRACTURE 39 0.0019
490 ATRIOVENTRICULAR BLOCK COMPLETE 13 0.0019
491 HYPERBILIRUBINAEMIA 20 0.0019
492 ASTHENIA 724 0.0019
493 TRANSFUSION 20 0.0019
494 ENTEROCOLITIS 11 0.0019
495 ORAL CANDIDIASIS 25 0.0019
496 GENERAL PHYSICAL HEALTH DETERIORATION 219 0.0019
497 TOOTH DISORDER 42 0.0019
498 HYPOVOLAEMIA 11 0.0019
499 HYPERTRIGLYCERIDAEMIA 11 0.0019
500 TRANSPLANT REJECTION 15 0.0019
501 BLOOD BILIRUBIN INCREASED 50 0.0018
502 DRUG INTOLERANCE 178 0.0018
503 BONE CANCER 8 0.0018
504 HEPATOCELLULAR INJURY 26 0.0018
505 DIVERTICULUM 13 0.0018
506 OEDEMA 99 0.0018
507 STAPHYLOCOCCAL SEPSIS 9 0.0018
508 NEPHROPATHY 17 0.0018
509 SUBDURAL HAEMATOMA 26 0.0018
510 ORGANISING PNEUMONIA 9 0.0018
511 IMMUNODEFICIENCY 27 0.0018
512 ARTERIOSCLEROSIS CORONARY ARTERY 12 0.0018
513 BLOOD PRESSURE ABNORMAL 36 0.0018
514 HAEMORRHAGE INTRACRANIAL 27 0.0018
515 HYPERKALAEMIA 63 0.0018
516 CORONARY ARTERY STENOSIS 9 0.0018
517 DISSEMINATED INTRAVASCULAR COAGULATION 25 0.0018
518 OLIGURIA 11 0.0018
519 OEDEMA PERIPHERAL 215 0.0018
520 DIARRHOEA 1135 0.0018
521 HAEMOPTYSIS 49 0.0018
522 COGNITIVE DISORDER 82 0.0018
523 GRANULOCYTOPENIA 10 0.0018
524 DEHYDRATION 233 0.0017
525 URINARY TRACT INFECTION 297 0.0017
526 IRON DEFICIENCY ANAEMIA 16 0.0017
527 TRANSIENT ISCHAEMIC ATTACK 58 0.0017
528 COLITIS 65 0.0017
529 TACHYCARDIA 151 0.0017
530 EPISTAXIS 127 0.0017
531 PURPURA 15 0.0017
532 DRUG ERUPTION 30 0.0017
533 HEPATITIS ACUTE 11 0.0017
534 CHILLS 198 0.0017
535 TOXIC SKIN ERUPTION 17 0.0017
536 CHOLECYSTITIS 20 0.0017
537 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 87 0.0017
538 HAEMODIALYSIS 14 0.0017
539 CHOLESTASIS 32 0.0017
540 NERVOUS SYSTEM DISORDER 52 0.0017
541 SARS-COV-2 TEST POSITIVE 22 0.0017
542 HEPATITIS CHOLESTATIC 10 0.0017
543 LOWER RESPIRATORY TRACT INFECTION 75 0.0016
544 NIGHT SWEATS 53 0.0016
545 HYPONATRAEMIA 92 0.0016
546 SPLENOMEGALY 19 0.0016
547 CONSTIPATION 351 0.0016
548 ILEUS 20 0.0016
549 INFARCTION 11 0.0016
550 LEUKOCYTOSIS 29 0.0016
551 CARDIO-RESPIRATORY ARREST 67 0.0016
552 URINE OUTPUT DECREASED 14 0.0016
553 HERPES ZOSTER 92 0.0016
554 ARTERIOSCLEROSIS 15 0.0016
555 SPINAL DISORDER 15 0.0016
556 DECREASED APPETITE 366 0.0016
557 CARDIAC ARREST 130 0.0016
558 CARDIAC VALVE DISEASE 9 0.0016
559 BLOOD URIC ACID INCREASED 9 0.0016
560 NO THERAPEUTIC RESPONSE 19 0.0016
561 FLUID RETENTION 79 0.0016
562 VASCULITIS 18 0.0015
563 METASTASIS 11 0.0015
564 LIVER DISORDER 68 0.0015
565 MALIGNANT NEOPLASM PROGRESSION 157 0.0015
566 NEOPLASM PROGRESSION 53 0.0015
567 SHOCK 35 0.0015
568 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 39 0.0015
569 HYPERLIPIDAEMIA 18 0.0015
570 TOXICITY TO VARIOUS AGENTS 254 0.0015
571 MOUTH HAEMORRHAGE 11 0.0015
572 TERMINAL STATE 10 0.0015
573 ADVERSE DRUG REACTION 134 0.0015
574 LEUKAEMIA 14 0.0015
575 BACK PAIN 343 0.0015
576 BASAL CELL CARCINOMA 23 0.0015
577 PULMONARY THROMBOSIS 16 0.0015
578 ACUTE HEPATIC FAILURE 20 0.0015
579 ASCITES 43 0.0015
580 CHOLANGITIS 9 0.0015
581 CONFUSIONAL STATE 234 0.0014
582 DELIRIUM 50 0.0014
583 COAGULOPATHY 24 0.0014
584 LARGE INTESTINE PERFORATION 10 0.0014
585 NEURALGIA 35 0.0014
586 TRANSAMINASES INCREASED 32 0.0014
587 BLOOD POTASSIUM DECREASED 43 0.0014
588 CATARACT 85 0.0014
589 CHRONIC KIDNEY DISEASE 108 0.0014
590 APPENDICITIS 13 0.0014
591 DIPLOPIA 36 0.0014
592 PYELONEPHRITIS 12 0.0014
593 ANGINA UNSTABLE 9 0.0014
594 GASTROINTESTINAL DISORDER 124 0.0014
595 NAUSEA 1095 0.0014
596 APHASIA 41 0.0014
597 GAMMA-GLUTAMYLTRANSFERASE INCREASED 30 0.0014
598 SHOCK HAEMORRHAGIC 11 0.0013
599 VENTRICULAR EXTRASYSTOLES 14 0.0013
600 HYPOACUSIS 58 0.0013
601 MUSCLE SPASMS 247 0.0013
602 MUSCLE ATROPHY 17 0.0013
603 HEPATIC FUNCTION ABNORMAL 50 0.0013
604 BODY TEMPERATURE INCREASED 27 0.0013
605 COUGH 367 0.0013
606 ACIDOSIS 10 0.0013
607 DRUG EFFECT INCOMPLETE 47 0.0013
608 FEMUR FRACTURE 40 0.0013
609 TASTE DISORDER 26 0.0013
610 PNEUMONIA ASPIRATION 32 0.0013
611 BRAIN OEDEMA 16 0.0013
612 CHEST PAIN 234 0.0013
613 HOSPITALISATION 194 0.0013
614 END STAGE RENAL DISEASE 23 0.0013
615 FOREIGN BODY SENSATION IN EYES 8 0.0013
616 HYPOPHAGIA 32 0.0013
617 INTESTINAL PERFORATION 14 0.0012
618 FACE OEDEMA 21 0.0012
619 STAPHYLOCOCCAL INFECTION 41 0.0012
620 DISEASE RECURRENCE 59 0.0012
621 RHINITIS 10 0.0012
622 INTERSTITIAL LUNG DISEASE 60 0.0012
623 ALANINE AMINOTRANSFERASE INCREASED 76 0.0012
624 RESPIRATORY DISORDER 37 0.0012
625 BRADYCARDIA 65 0.0012
626 LOWER GASTROINTESTINAL HAEMORRHAGE 9 0.0012
627 FRACTURE 23 0.0012
628 PROTEINURIA 23 0.0012
629 MUSCULOSKELETAL DISORDER 23 0.0012
630 COLON CANCER 18 0.0012
631 SKIN LESION 33 0.0012
632 HYPOTENSION 240 0.0012
633 HEPATIC ENZYME INCREASED 81 0.0012
634 BLOOD PRESSURE INCREASED 181 0.0012
635 LIPASE INCREASED 9 0.0012
636 CIRCULATORY COLLAPSE 20 0.0012
637 INSOMNIA 312 0.0012
638 THERAPEUTIC RESPONSE DECREASED 71 0.0012
639 LACERATION 11 0.0012
640 DIFFUSE LARGE B-CELL LYMPHOMA 9 0.0012
641 AGEUSIA 29 0.0012
642 OSTEOMYELITIS 21 0.0012
643 DYSGEUSIA 86 0.0012
644 BLOOD CALCIUM DECREASED 13 0.0012
645 PELVIC FRACTURE 9 0.0012
646 HAEMORRHAGIC STROKE 9 0.0012
647 PRESYNCOPE 28 0.0012
648 HYPERTRANSAMINASAEMIA 8 0.0011
649 VOMITING 540 0.0011
650 PULMONARY FIBROSIS 22 0.0011
651 TOOTH INFECTION 15 0.0011
652 SMALL INTESTINAL OBSTRUCTION 14 0.0011
653 SKIN REACTION 16 0.0011
654 BLOOD ALBUMIN DECREASED 9 0.0011
655 PRODUCTIVE COUGH 54 0.0011
656 UPPER GASTROINTESTINAL HAEMORRHAGE 19 0.0011
657 CORONARY ARTERY DISEASE 34 0.0011
658 STOMATITIS 68 0.0011
659 HAEMATOCRIT DECREASED 22 0.0011
660 ALTERED STATE OF CONSCIOUSNESS 24 0.0011
661 CHEST DISCOMFORT 112 0.0011
662 UPPER-AIRWAY COUGH SYNDROME 9 0.0011
663 ORTHOSTATIC HYPOTENSION 19 0.0011
664 EOSINOPHILIA 19 0.0011
665 PERIPHERAL SWELLING 167 0.0011
666 SKIN DISORDER 36 0.0011
667 ADRENAL INSUFFICIENCY 13 0.0011
668 DIARRHOEA HAEMORRHAGIC 10 0.0011
669 NASOPHARYNGITIS 197 0.0011
670 PANCREATITIS ACUTE 24 0.0011
671 MYOCARDIAL INFARCTION 186 0.0011
672 LIVER FUNCTION TEST ABNORMAL 31 0.0011
673 FACIAL PARALYSIS 9 0.0011
674 HEPATITIS 27 0.0011
675 RASH PRURITIC 57 0.0011
676 HYPERSOMNIA 30 0.0010
677 SLEEP DISORDER 73 0.0010
678 CEREBRAL HAEMORRHAGE 37 0.0010
679 SPINAL OSTEOARTHRITIS 9 0.0010
680 CEREBRAL INFARCTION 25 0.0010
681 RASH 445 0.0010
682 TREATMENT FAILURE 84 0.0010
683 BLOOD ALKALINE PHOSPHATASE INCREASED 25 0.0010
684 SCIATICA 16 0.0010
685 METABOLIC ACIDOSIS 32 0.0010
686 ASPARTATE AMINOTRANSFERASE INCREASED 53 0.0010
687 GASTROENTERITIS VIRAL 18 0.0010
688 MALAISE 437 0.0010
689 HEPATIC FAILURE 30 0.0010
690 HIP FRACTURE 32 0.0010
691 LOCALISED INFECTION 24 0.0010
692 DRUG-INDUCED LIVER INJURY 31 0.0010
693 RECTAL HAEMORRHAGE 42 0.0010
694 EAR INFECTION 26 0.0010
695 HEPATIC STEATOSIS 18 0.0010
696 WHITE BLOOD CELL COUNT INCREASED 37 0.0010
697 FLANK PAIN 9 0.0010
698 HEPATIC CIRRHOSIS 18 0.0010
699 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 28 0.0010
700 WEIGHT FLUCTUATION 10 0.0010
701 MUSCULOSKELETAL PAIN 50 0.0010
702 GALLBLADDER DISORDER 17 0.0010
703 EYELID OEDEMA 11 0.0009
704 DEPRESSED LEVEL OF CONSCIOUSNESS 37 0.0009
705 BODY HEIGHT DECREASED 10 0.0009
706 UNRESPONSIVE TO STIMULI 24 0.0009
707 URINARY RETENTION 31 0.0009
708 TOXIC EPIDERMAL NECROLYSIS 14 0.0009
709 SKIN LACERATION 10 0.0009
710 MOBILITY DECREASED 66 0.0009
711 LOCAL SWELLING 16 0.0009
712 CONJUNCTIVITIS 17 0.0009
713 OESOPHAGITIS 10 0.0009
714 BEDRIDDEN 12 0.0009
715 GASTRITIS 24 0.0009
716 WEIGHT DECREASED 254 0.0009
717 DRUG EFFECT DECREASED 49 0.0009
718 GASTROINTESTINAL HAEMORRHAGE 76 0.0009
719 TOOTH FRACTURE 10 0.0009
720 LETHARGY 52 0.0009
721 TREMOR 150 0.0009
722 UPPER LIMB FRACTURE 18 0.0009
723 FUNGAL INFECTION 30 0.0009
724 MUSCULAR WEAKNESS 102 0.0009
725 LIVER INJURY 22 0.0009
726 BLOOD UREA INCREASED 15 0.0009
727 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 49 0.0009
728 SINUS CONGESTION 12 0.0009
729 INFLUENZA LIKE ILLNESS 73 0.0009
730 PHARYNGITIS 11 0.0009
731 STATUS EPILEPTICUS 10 0.0009
732 TOOTH ABSCESS 9 0.0009
733 TOOTHACHE 16 0.0009
734 C-REACTIVE PROTEIN INCREASED 32 0.0009
735 PALPITATIONS 103 0.0009
736 SINUSITIS 90 0.0009
737 MUSCULOSKELETAL DISCOMFORT 15 0.0009
738 POOR VENOUS ACCESS 9 0.0009
739 BLOOD POTASSIUM INCREASED 14 0.0009
740 ACTIVITIES OF DAILY LIVING IMPAIRED 17 0.0009
741 OXYGEN SATURATION DECREASED 48 0.0009
742 EPILEPSY 26 0.0008
743 RENAL INJURY 25 0.0008
744 BRONCHOSPASM 12 0.0008
745 FEELING ABNORMAL 201 0.0008
746 DISTURBANCE IN ATTENTION 45 0.0008
747 RENAL FAILURE ACUTE 35 0.0008
748 DEMENTIA 23 0.0008
749 JAUNDICE 22 0.0008
750 CYSTITIS 26 0.0008
751 GLOMERULAR FILTRATION RATE DECREASED 10 0.0008
752 DENTAL CARIES 9 0.0008
753 VISUAL ACUITY REDUCED 27 0.0008
754 VENTRICULAR FIBRILLATION 9 0.0008
755 CEREBROVASCULAR ACCIDENT 137 0.0008
756 SINUS DISORDER 16 0.0008
757 PULMONARY MASS 12 0.0008
758 ORAL PAIN 18 0.0008
759 CENTRAL NERVOUS SYSTEM LESION 11 0.0008
760 EYE INFECTION 9 0.0008
761 HYPOAESTHESIA ORAL 12 0.0008
762 BLOOD SODIUM DECREASED 15 0.0008
763 POOR QUALITY SLEEP 17 0.0008
764 DYSPHONIA 46 0.0008
765 THERAPEUTIC PRODUCT EFFECT DECREASED 35 0.0008
766 GLAUCOMA 15 0.0008
767 PAIN IN JAW 22 0.0008
768 ABASIA 19 0.0008
769 HEMIPARESIS 13 0.0008
770 DYSURIA 28 0.0008
771 HAEMATURIA 26 0.0008
772 HYPOKINESIA 11 0.0008
773 DISORIENTATION 30 0.0008
774 ACCIDENTAL EXPOSURE TO PRODUCT 78 0.0008
775 THYROID CANCER 9 0.0007
776 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
777 PHOTOPHOBIA 14 0.0007
778 DYSPEPSIA 73 0.0007
779 HYPOAESTHESIA 110 0.0007
780 EYE DISORDER 24 0.0007
781 CORONARY ARTERY OCCLUSION 10 0.0007
782 TOOTH EXTRACTION 9 0.0007
783 GASTROOESOPHAGEAL REFLUX DISEASE 58 0.0007
784 SOMNOLENCE 145 0.0007
785 PANCREATITIS 38 0.0007
786 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
787 HEART RATE INCREASED 70 0.0007
788 FALL 234 0.0007
789 ROTATOR CUFF SYNDROME 9 0.0007
790 THINKING ABNORMAL 13 0.0007
791 SKIN CANCER 15 0.0007
792 RASH GENERALISED 18 0.0007
793 ABDOMINAL DISTENSION 72 0.0007
794 DISCOMFORT 42 0.0007
795 PAIN IN EXTREMITY 201 0.0007
796 MELAENA 15 0.0007
797 LUNG NEOPLASM MALIGNANT 28 0.0007
798 BACK DISORDER 11 0.0007
799 ILL-DEFINED DISORDER 41 0.0007
800 EYE HAEMORRHAGE 9 0.0007
801 BLOOD IRON DECREASED 8 0.0007
802 METASTASES TO BONE 11 0.0007
803 ANAPHYLACTIC REACTION 37 0.0007
804 GOUT 12 0.0007
805 EAR PAIN 13 0.0007
806 HAEMORRHOIDS 13 0.0007
807 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 32 0.0007
808 UVEITIS 9 0.0007
809 VISION BLURRED 91 0.0007
810 DEPRESSED MOOD 35 0.0007
811 RESTLESS LEGS SYNDROME 12 0.0007
812 GINGIVAL BLEEDING 9 0.0007
813 DRUG INEFFECTIVE 867 0.0007
814 WHEEZING 39 0.0007
815 INJECTION SITE EXTRAVASATION 8 0.0006
816 GAIT DISTURBANCE 124 0.0006
817 NECK PAIN 36 0.0006
818 SEASONAL ALLERGY 9 0.0006
819 SWELLING FACE 41 0.0006
820 PERITONITIS 13 0.0006
821 PARAESTHESIA ORAL 9 0.0006
822 ANOSMIA 9 0.0006
823 MENTAL DISORDER 27 0.0006
824 HEART RATE IRREGULAR 14 0.0006
825 ABDOMINAL PAIN 144 0.0006
826 PAIN 380 0.0006
827 HIATUS HERNIA 8 0.0006
828 HAEMATOMA 16 0.0006
829 MOUTH ULCERATION 13 0.0006
830 NEOPLASM MALIGNANT 41 0.0006
831 HAEMORRHAGE 64 0.0006
832 MULTIPLE FRACTURES 10 0.0006
833 PELVIC PAIN 11 0.0006
834 DIABETES MELLITUS 46 0.0006
835 RHINORRHOEA 39 0.0006
836 TREATMENT NONCOMPLIANCE 33 0.0006
837 INTERVERTEBRAL DISC PROTRUSION 13 0.0006
838 OROPHARYNGEAL PAIN 55 0.0006
839 OCULAR HYPERAEMIA 28 0.0006
840 HEADACHE 368 0.0006
841 BLOOD PRESSURE FLUCTUATION 14 0.0006
842 CONTUSION 56 0.0006
843 DRY EYE 29 0.0006
844 NASAL CONGESTION 34 0.0006
845 MENTAL IMPAIRMENT 14 0.0006
846 URINARY INCONTINENCE 17 0.0006
847 PRODUCT USE IN UNAPPROVED INDICATION 141 0.0006
848 HEAD INJURY 18 0.0006
849 RESPIRATORY TRACT CONGESTION 9 0.0006
850 EATING DISORDER 12 0.0006
851 PARAESTHESIA 88 0.0006
852 DIZZINESS 278 0.0006
853 SKIN EXFOLIATION 47 0.0006
854 BURNING SENSATION 39 0.0006
855 MEMORY IMPAIRMENT 76 0.0006
856 LIMB DISCOMFORT 17 0.0005
857 BALANCE DISORDER 47 0.0005
858 INFLAMMATION 28 0.0005
859 DRY MOUTH 44 0.0005
860 SKIN ULCER 14 0.0005
861 BLOOD GLUCOSE ABNORMAL 10 0.0005
862 STEVENS-JOHNSON SYNDROME 12 0.0005
863 HYPERHIDROSIS 69 0.0005
864 DEAFNESS 14 0.0005
865 HYPERSENSITIVITY 99 0.0005
866 INTESTINAL OBSTRUCTION 20 0.0005
867 SEIZURE 61 0.0005
868 POLLAKIURIA 22 0.0005
869 FOOT FRACTURE 10 0.0005
870 NEPHROLITHIASIS 24 0.0005
871 CHOLELITHIASIS 17 0.0005
872 ANKLE FRACTURE 8 0.0005
873 HAEMATEMESIS 13 0.0005
874 ABDOMINAL DISCOMFORT 86 0.0005
875 BRAIN FOG 8 0.0005
876 KIDNEY INFECTION 10 0.0005
877 HEAD DISCOMFORT 9 0.0005
878 MYALGIA 86 0.0005
879 ANAPHYLACTIC SHOCK 13 0.0005
880 ABSCESS 8 0.0005
881 TINNITUS 23 0.0005
882 OSTEOARTHRITIS 21 0.0005
883 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 35 0.0005
884 CHROMATURIA 11 0.0005
885 HEART RATE DECREASED 17 0.0005
886 SWELLING 45 0.0005
887 LIMB INJURY 13 0.0005
888 DERMATITIS 10 0.0005
889 THERAPY INTERRUPTED 34 0.0005
890 TYPE 2 DIABETES MELLITUS 16 0.0005
891 FEELING JITTERY 9 0.0005
892 FLUSHING 48 0.0005
893 RETCHING 10 0.0005
894 ASTHMA 53 0.0005
895 LOWER LIMB FRACTURE 9 0.0005
896 LOSS OF CONSCIOUSNESS 60 0.0005
897 BLOOD PRESSURE DECREASED 31 0.0005
898 HERNIA 9 0.0005
899 LACRIMATION INCREASED 14 0.0005
900 PRURITUS GENERALISED 10 0.0005
901 VISUAL IMPAIRMENT 57 0.0005
902 EYE SWELLING 17 0.0005
903 COLD SWEAT 8 0.0005
904 BLOOD TRIGLYCERIDES INCREASED 8 0.0005
905 LYMPHADENOPATHY 16 0.0005
906 RASH PAPULAR 10 0.0004
907 PALLOR 12 0.0004
908 AGGRESSION 22 0.0004
909 HYPOTHYROIDISM 14 0.0004
910 WOUND 12 0.0004
911 WEIGHT INCREASED 96 0.0004
912 ILLNESS 44 0.0004
913 EYE PAIN 24 0.0004
914 JOINT SWELLING 51 0.0004
915 GAIT INABILITY 14 0.0004
916 INCREASED APPETITE 8 0.0004
917 ERYTHEMA 86 0.0004
918 BLINDNESS 17 0.0004
919 BLOOD GLUCOSE INCREASED 78 0.0004
920 SKIN DISCOLOURATION 19 0.0004
921 NERVOUSNESS 21 0.0004
922 ARTHRALGIA 167 0.0004
923 THROAT IRRITATION 18 0.0004
924 DEPRESSION 91 0.0004
925 HAEMATOCHEZIA 22 0.0004
926 FEEDING DISORDER 8 0.0004
927 ARTHRITIS 31 0.0004
928 VERTIGO 24 0.0004
929 FLATULENCE 22 0.0004
930 URTICARIA 64 0.0004
931 ARTHROPATHY 21 0.0004
932 RASH ERYTHEMATOUS 18 0.0004
933 ABDOMINAL PAIN UPPER 77 0.0004
934 PRURITUS 143 0.0004
935 CONDITION AGGRAVATED 113 0.0004
936 AMNESIA 24 0.0004
937 DYSPHAGIA 35 0.0004
938 PRODUCT USE ISSUE 69 0.0004
939 OSTEONECROSIS 12 0.0004
940 THERAPEUTIC RESPONSE UNEXPECTED 16 0.0004
941 RESTLESSNESS 13 0.0004
942 ANXIETY 100 0.0004
943 HYPOGLYCAEMIA 17 0.0004
944 GASTRIC DISORDER 12 0.0003
945 HOT FLUSH 26 0.0003
946 FEELING HOT 21 0.0003
947 DYSSTASIA 10 0.0003
948 FEELING COLD 9 0.0003
949 BLOOD CHOLESTEROL INCREASED 15 0.0003
950 PRODUCT DOSE OMISSION 21 0.0003
951 INTENTIONAL DOSE OMISSION 9 0.0003
952 AGITATION 23 0.0003
953 ROAD TRAFFIC ACCIDENT 13 0.0003
954 OSTEOPOROSIS 12 0.0003
955 DRUG DOSE OMISSION 48 0.0003
956 ECZEMA 15 0.0003
957 SPEECH DISORDER 15 0.0003
958 MOOD SWINGS 9 0.0003
959 COMA 13 0.0003
960 IRRITABILITY 16 0.0003
961 HALLUCINATION 20 0.0003
962 BLISTER 14 0.0002
963 PROSTATE CANCER 20 0.0002
964 ANGIOEDEMA 11 0.0002
965 IMPAIRED HEALING 8 0.0002
966 PRODUCT DOSE OMISSION ISSUE 71 0.0002
967 DYSARTHRIA 9 0.0002
968 SURGERY 14 0.0002
969 EYE PRURITUS 8 0.0002
970 ANGER 8 0.0002
971 ALOPECIA 46 0.0002
972 DRUG INTERACTION 36 0.0002
973 INCORRECT ROUTE OF DRUG ADMINISTRATION 8 0.0002
974 RHABDOMYOLYSIS 9 0.0002
975 MIGRAINE 20 0.0002
976 BLOOD GLUCOSE DECREASED 10 0.0002
977 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 41 0.0002
978 EXTRA DOSE ADMINISTERED 8 0.0002
979 THERAPY CESSATION 10 0.0002
980 INTENTIONAL PRODUCT MISUSE 16 0.0002
981 BREAST CANCER 16 0.0002
982 MUSCULOSKELETAL STIFFNESS 15 0.0002
983 DRY SKIN 21 0.0002
984 EYE IRRITATION 9 0.0002
985 SKIN BURNING SENSATION 11 0.0002
986 PSORIASIS 20 0.0002
987 OVERDOSE 33 0.0002
988 INJURY 10 0.0001
989 CONVULSION 8 0.0001
990 NO ADVERSE EVENT 25 0.0001
991 BLADDER CANCER 8 0.0001
992 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
993 INCORRECT DOSE ADMINISTERED 22 0.0001
994 INJECTION SITE ERYTHEMA 10 0.0001
995 EMOTIONAL DISTRESS 9 0.0001
996 INJECTION SITE PAIN 21 0.0001